Abstract: Objective: Low-density granulocytes (LDGs) can form neutrophil extracellular traps (NETs) spontaneously and excessively. When peripheral blood mononuclear cells (PBMCs) are used for studying T lymphocytes, LDGs contained in the PBMCs may decrease the threshold of activating T lymphocytes by forming NETs. This study focused on the profiles of LDGs in common autoimmune diseases and methods for removing LDGs from PBMCs. Methods: The percentages of LDGs in PBMCs from 55 patients with dermatomyositis (DM), 15 with polymyositis (PM), 42 with rheumatoid arthritis (RA), 25 with systemic lupus erythematosus (SLE), and 19 healthy controls were determined by flow cytometry. Three methods of removing LDGs were explored and compared. After removal, PBMCs from six patients with positive T-SPOT.TB were tested again to find out if LDGs contained in the PBMCs could influence T lymphocyte reactions. Results: Significantly higher LDG percentages were found in PBMCs from patients with DM ((8.41±10.87)%, P<0.0001), PM ((8.41±10.39)%, P<0.0001), RA ((4.05±6.97)%, P=0.0249), and SLE ((7.53±11.52)%, P=0.0006), compared with the controls ((1.28±0.73)%). The T-SPOT.TB values significantly decreased after LDGs were removed. Increasing relative centrifugal force (RCF) within a limited range can decrease the LDG percentage from an initial high level, but not markedly increase the LDG clearance rate. Compared with the whole blood sediment method, the PBMC adherence method can significantly remove LDGs yet scarcely influence the T lymphocyte percentage in PBMCs. Conclusions: The LDG percentage in PBMCs is significantly increased in patients with SLE, DM, PM, and RA. The influence of LDGs on T lymphocytes cannot be ignored in PBMC cultures. The adherence method is a simple and easy-to-use method for removing LDGs and purifying T lymphocytes from PBMCs.

一种从外周血单个核细胞中祛除低密度粒细胞并纯化T淋巴细胞的简易方法

[1]Aletaha, D., Neogi, T., Silman, A.J., et al., 2010. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis., 69(9):1580-1588.

[2]Bohan, A., Peter, J.B., 1975a. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med., 292(7):344-347.

[3]Bohan, A., Peter, J.B., 1975b. Polymyositis and dermatomyositis (second of two parts). N. Engl. J. Med., 292(8):403-407.

[4]Brinkmann, V., Reichard, U., Goosmann, C., et al., 2004. Neutrophil extracellular traps kill bacteria. Science, 303(5663):1532-1535.

[5]Carmona-Rivera, C., Kaplan, M.J., 2013. Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity. Semin. Immunopathol., 35(4):455-463.

[6]Carmona-Rivera, C., Zhao, W., Yalavarthi, S., et al., 2015. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann. Rheum. Dis., 74(7):1417-1424.

[7]Cloke, T., Munder, M., Taylor, G., et al., 2012. Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infection. PLoS ONE, 7(11):e48939.

[8]Cloke, T., Munder, M., Bergin, P., et al., 2013. Phenotypic alteration of neutrophils in the blood of HIV seropositive patients. PLoS ONE, 8(9):e72034.

[9]Denny, M.F., Yalavarthi, S., Zhao, W., et al., 2010. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol., 184(6):3284-3297.

[10]Fuchs, T.A., Abed, U., Goosmann, C., et al., 2007. Novel cell death program leads to neutrophil extracellular traps. J. Cell. Biol., 176(2):231-241.

[11]Hacbarth, E., Kajdacsy-Balla, A., 1986. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum., 29(11):1334-1342.

[12]Hochberg, M.C., 1997. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 40(9):1725-1734.

[13]Hoffmann, M.H., Bruns, H., Bäckdahl, L., et al., 2013. The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats. Ann. Rheum. Dis., 72(7):1239-1248.

[14]Lin, A.M., Rubin, C.J., Khandpur, R., et al., 2011. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J. Immunol., 187(1):490-500.

[15]Morisaki, T., Goya, T., Ishimitsu, T., et al., 1992. The increase of low density subpopulations and CD10 (CALLA) negative neutrophils in severely infected patients. Surg. Today, 22(4):322-327.

[16]Pavón, E.J., García-Rodríguez, S., Zumaquero, E., et al., 2012. Increased expression and phosphorylation of the two S100A9 isoforms in mononuclear cells from patients with systemic lupus erythematosus: a proteomic signature for circulating low-density granulocytes. J. Proteomics, 75(6):1778-1791.

[17]Rodriguez, P.C., Ernstoff, M.S., Hernandez, C., et al., 2009. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res., 69(4):1553-1560.

[18]Saffarzadeh, M., Juenemann, C., Queisser, M.A., et al., 2012. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE, 7(2):e32366.

[19]Ssemaganda, A., Kindinger, L., Bergin, P., et al., 2014. Characterization of neutrophil subsets in healthy human pregnancies. PLoS ONE, 9(2):e85696.

[20]Tillack, K., Breiden, P., Martin, R., et al., 2012. T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. J. Immunol., 188(7):3150-3159.

[21]Villanueva, E., Yalavarthi, S., Berthier, C.C., et al., 2011. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol., 187(1):538-552.